LINK WILLIAM J PHD 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 29, 2026
Research Summary
AI-generated summary of this filing
Tarsus (TARS) Director William J. Link Receives RSUs and Options
What Happened
William J. Link, Ph.D., a director of Tarsus Pharmaceuticals (TARS), was awarded equity on 2026-06-25 consisting of a 3,837‑unit annual stock option grant and two restricted stock unit (RSU) awards totaling 3,223 RSUs (2,417 RSUs and 806 RSUs). The reported price for each grant is $0.00 because these are equity awards; no cash changed hands at grant.
Key Details
- Transaction date: 2026-06-25; Form 4 filed 2026-06-29 (filed within customary two business days).
- Awards: 3,837 (option award, footnote F1) + 2,417 RSUs (F3) + 806 RSUs (F4) = 7,060 total units. Reported acquisition code: A (award/grant).
- Reported price: $0.00 for each award (standard for grants). No sale or open‑market purchase occurred.
- Vesting: The 3,837 option vests in full one year after grant (F1). The 2,417 RSUs vest in full on the one‑year anniversary (F3). The 806 RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027 (F4). All vesting is subject to continuous service as a non‑employee director.
- Shares owned after transaction: not specified in the provided data from the filing.
- Transaction type/implication: award/grant (neutral routine director compensation), not an open‑market purchase or sale.
Context
RSUs are contingent rights to receive common stock at vesting; options are derivative rights to purchase stock under plan terms. These grants are routine director compensation disclosed on Form 4 and do not by themselves indicate an intent to buy or sell stock immediately.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-06-25+3,837→ 3,837 totalExercise: $64.34Exp: 2036-06-24→ Common Stock (3,837 underlying) - Award
Restricted Stock Units
[F2][F3]2026-06-25+2,417→ 2,417 total→ Common Stock (2,417 underlying) - Award
Restricted Stock Units
[F2][F4]2026-06-25+806→ 806 total→ Common Stock (806 underlying)
Footnotes (4)
- [F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- [F4]RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service.